175 related articles for article (PubMed ID: 24377569)
21. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
22. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
[No Abstract] [Full Text] [Related]
23. Synergistic anticancer activity of dietary tea polyphenols and bleomycin hydrochloride in human cervical cancer cell: Caspase-dependent and independent apoptotic pathways.
Alshatwi AA; Periasamy VS; Athinarayanan J; Elango R
Chem Biol Interact; 2016 Mar; 247():1-10. PubMed ID: 26800624
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.
Lv M; Ou R; Zhang Q; Lin F; Li X; Wang K; Xu Y
Drug Des Devel Ther; 2019; 13():2371-2379. PubMed ID: 31409971
[TBL] [Abstract][Full Text] [Related]
25. [Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells].
Shi YR; Liu J; He W; Yang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):697-702. PubMed ID: 28598082
[TBL] [Abstract][Full Text] [Related]
26. MiRNA373 induces cervical squamous cell carcinoma SiHa cell apoptosis.
Fan L; Liu Z; Zhang Y; Zhu H; Yu H; Yang F; Yang R; Wu F
Cancer Biomark; 2018 Feb; 21(2):455-460. PubMed ID: 29125482
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
[TBL] [Abstract][Full Text] [Related]
28. MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
Zhang W; Zhou J; Zhu X; Yuan H
Gene; 2017 Sep; 627():420-427. PubMed ID: 28669929
[TBL] [Abstract][Full Text] [Related]
29. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
30. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
31.
Hung PS; Chuang FJ; Chen CY; Chou CH; Tu HF; Lo SS
Anticancer Res; 2020 Mar; 40(3):1427-1436. PubMed ID: 32132039
[TBL] [Abstract][Full Text] [Related]
32. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.
Yi Y; Li H; Lv Q; Wu K; Zhang W; Zhang J; Zhu D; Liu Q; Zhang W
Oncotarget; 2016 Nov; 7(44):72067-72075. PubMed ID: 27732565
[TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
[No Abstract] [Full Text] [Related]
34. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
35. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
36. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
37. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
38. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
39. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]